Skip to main content

Posts

Showing posts from March 30, 2025

Couple with Parrot, Pieter de Hooch (1668)

  Public Domain. Source: WikiArt,  https://www.wikiart.org/en/pieter-de-hooch/couple-with-parrot-1668 ____

#Coronavirus Disease Research #References (by AMEDEO, March 30 '25)

  Ann Intern Med GRANWEHR BP CBT and rehabilitation improved long COVID symptoms. Ann Intern Med. 2025;178:JC28. PubMed           Abstract available BMJ WISE J Covid-19: Inquiry hears of doctors' lack of confidence in PPE as ministers defend VIP lane. BMJ. 2025;388:r584. PubMed          Clin Infect Dis ALLAN-BLITZ LT, Klausner JD Shifting the Focus in Acute SARS-CoV-2 Management to Include Prevention of Long-COVID. Clin Infect Dis. 2025 Mar 26:ciaf158. doi: 10.1093. PubMed          Emerg Infect Dis SANDER B, Mishra S, Swayze S, Sahakyan Y, et al Population-Based Matched Cohort Study of COVID-19 Healthcare Costs, Ontario, Canada. Emerg Infect Dis. 2025;31:710-719. PubMed           Abstract available Intensive Care Med BIHLMAIER K, Willam C, Herbst L, Hackstein H, et al Rapid clinical effects of convalescent plasma therapy in severe COV...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, March 30 '25)

  Ann Intern Med GRANWEHR BP CBT and rehabilitation improved long COVID symptoms. Ann Intern Med. 2025;178:JC28. PubMed           Abstract available IOANNOU GN, Berry K, Rajeevan N, Li Y, et al Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation. Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015. PubMed           Abstract available Antiviral Res KUO YS, Chiang PC, Kuo CY, Huang CG, et al Inhibition of influenza A virus proliferation in mice via universal RNA interference. Antiviral Res. 2025 Mar 25:106149. doi: 10.1016/j.antiviral.2025.106149. PubMed           Abstract available Arch Virol YE QY, Jiang ZT, Jiang Y, Cai JW, et al Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant. Arch Virol. 2025;170:88. PubMed ...

Modeling the #impact of early #vaccination in an #influenza #pandemic in the #USA

Abstract We modeled the impact of initiating one-dose influenza vaccination at 3 months vs 6 months after declaration of a pandemic over a 1-year timeframe in the US population. Three vaccine effectiveness (VE) and two pandemic severity levels were considered, using an epidemic curve based on typical seasonal influenza epidemics. Vaccination from 3 months with a high, moderate, or low effectiveness vaccine would prevent ~95%, 84%, or 38% deaths post-vaccination, respectively, compared with 21%, 18%, and 8%, respectively following vaccination at 6 months, irrespective of pandemic severity. While the pandemic curve would not be flattened from vaccination from 6 months , a moderate/high effectiveness vaccine could flatten the curve if administered from 3 months. Overall, speed of initiating a vaccination campaign is more important than VE in reducing the health impacts of an influenza pandemic. Preparedness strategies may be able to minimize future pandemic impacts by prioritizing rapid v...